Overactive Bladder Innovative Therapy Trial (OrBIT)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Overactive Bladder
Related studies linked through entity extraction aliases.
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)
- Status
- COMPLETED
- Phase
- PHASE3
Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity
- Status
- COMPLETED
- Phase
- N/A
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity
- Status
- UNKNOWN
- Phase
- N/A
Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR)
- Status
- COMPLETED
- Phase
- PHASE4
Local Anesthetic Treatments for Overactive Bladder
- Status
- TERMINATED
- Phase
- PHASE3
A Two-Part Study to Determine: Best Medication Formulation and Food Effect
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
- Status
- COMPLETED
- Phase
- PHASE3
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)
- Status
- COMPLETED
- Phase
- PHASE2
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
- Status
- UNKNOWN
- Phase
- PHASE4
Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
- Status
- COMPLETED
- Phase
- PHASE2
Surface Nerve Stimulation Treatment for OAB in Children
- Status
- COMPLETED
- Phase
- NA